Editor’s Note: As a hospital Laboratory Director, my first questions regarding he COVID-19 virus was…has it been isolated? If not, this dis-ease does not exist! My instincts have been correct for myself. I urge all others to investigate, ask questions, follow your own gut instinct, and then BE in…
All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
First published by GR on August 10, 2021
Hell is Empty and the Devils are All Here, William Shakespeare, The Tempest, 1610- 1611
There is a sequence of outright lies and fabrications used to justify far-reaching policy decisions which in the course of the last 18 months are literally destroying people’s lives Worldwide.
“Fake science” is used to justify confinement, social distancing, the face mask, the prohibition of social gatherings, cultural and sports events, the closure of economic activity, all of which are upheld as a means to repealing the “killer virus”.
Who is this “Killer Virus” which has been personified by both the media and our governments, held responsible for triggering economic and social chaos Worldwide?
You might recall that at the height of the February 2020 financial collapse, “V the Virus” was held responsible for the largest stock market crash since 1929.
Has the “Killer Virus” been Identified. Has SARS-CoV-2 been Isolated?
This article will review this contentious issue starting at the outset of the crisis in January 2020. Part of this analysis is based on research conducted in early 2020.
The central question raised in this review is the following: is there reliable evidence provided by the WHO and national health authorities that the alleged SARS-CoV-2 virus has been isolated/purified from an “unadulterated sample taken from a diseased patient”?
While the alleged virus was initially defined as the 2019 novel coronavirus (2019-nCoV) in January 2020, the World Health Organization (WHO) did not have in its possession details regarding the isolation/purification and identity of 2019-nCoV.
And because details concerning isolation / purification were not available, the WHO decided to “customize” The Real Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Test using the alleged “similar” 2003 SARS virus (subsequently renamed SARS-1) as “a point of reference” for detecting genetic fragments of the novel 2019-nCoV.
What this decision entails is that novel 2019-CoV-2 is NOT a novel virus. It was categorized by the Chinese authorities and the WHO as “similar” to the 2003 SARS-CoV as well as to MERS.
2003 SARS-CoV was subsequently renamed SARS-CoV-1.
History: Isolation of the Virus
Chinese Health Authorities
The Chinese authorities announced on January 7, 2020 that “a new type of virus” had been identified “similar to the one associated with SARS and MERS” (related report , not original Chinese government source). The underlying method is described below:
We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing.
Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. (emphasis added)
The following article entitled “A new coronavirus associated with human respiratory disease in China, (Nature, February 3, 2021) was among the first to report on China’s novel coronavirus:
…[We] collected bronchoalveolar lavage fluid (BALF) and performed deep meta-transcriptomic sequencing. The clinical specimen was handled in a biosafety level 3 laboratory at Shanghai Public Health Clinical Center. Total RNA was extracted from 200 μl of BALF and a meta-transcriptomic library was constructed for pair-end (150-bp reads) sequencing using an Illumina MiniSeq as previously described 4,6,7,8.
In total, we generated 56,565,928 sequence reads that were de novo-assembled and screened for potential aetiological agents.
The genome sequence of this virus, as well as its termini, were determined and confirmed by reverse-transcription PCR (RT–PCR)10 and 5′/3′ rapid amplification of cDNA ends (RACE), respectively. This virus strain was designated as WH-Human 1 coronavirus (WHCV) (and has also been referred to as ‘2019-nCoV’) and its whole genome sequence (29,903 nt) has been assigned GenBank accession number MN908947.
The viral genome organization of WHCV was determined by sequence alignment to two representative members of the genus Betacoronavirus: a coronavirus associated with humans (SARS-CoV Tor2, GenBank accession number AY274119)  and a coronavirus associated with bats (bat SL-CoVZC45, GenBank accession number MG772933) . (Nature, February 3, 2020)
It is unclear from the above quotations as well as from the documents consulted, whether the Chinese health authorities undertook an isolation / purification of a patient’s specimen.
US Centre for Disease Control and Prevention (CDC)
Following the Chinese announcement on the 28th of January 2020, the US Centre for Disease Control and Prevention (CDC) stated that the novela corona virus had been isolated.The CDC statement dated January 28th, 2020 (updated December 2020) is unequivocal:
SARS-CoV-2, the virus that causes COVID-19, was isolated in the laboratory and is available for research by the scientific and medical community.
- On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study.
- On February 2, 2020, CDC generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers.
- On February 4, 2020, CDC shipped SARS-CoV-2 to the BEI Resources Repository.
- An article discussing the isolation and characterization of this virus specimen is available in Emerging Infectious Diseases.
One important way that CDC has supported global efforts to study and learn about SARS-CoV-2 in the laboratory was by growing the virus in cell culture and ensuring that it was widely available. Researchers in the scientific and medical community can use virus obtained from this work in their studies.
SARS-CoV-2 strains supplied by CDC and other researchers can be requested, free, from the Biodefense and Emerging Infections Research (BEI) Resources Repositoryexternal icon by established institutions that meet BEI requirements. These requirements include maintaining appropriate facilities and safety programs, as well as having the appropriate expertise. BEI supplies organisms and reagents to the broader community of microbiology and infectious disease researchers. (Emphasis added).
See also related study which was posted on the CDC website.